My Theory is PAA need to increase market awareness.
Volume is anemic in the low 1000's or Zero ,, Presenting at Biotech Conferences would definitely raise the companys profile.
Investors are generally seeking one thing,,, a Return on Investment ,, PAA have begun including Commercial Value in Announcements which is great to see...
Possibly a media presentation , couple of minutes long outlining the the current Treatments that are being Trialed and what a commercial outcome might look like?
Company could identify all the hard work that has been completed demonstrating the finish line is in sight? and that there is a finish line...
Ann: First Patient of Cohort 2 Dosed in MND Trial, page-69
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $83.69M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $70.91K | 420.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 104900 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 186536 | 2 |
View Market Depth
| Last trade - 15.35pm 14/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |